• Users Online: 529
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others


The endocannabinoid system and stroke: A focused review

Kolb Bradley, Saber Hamidreza, Fadel Hassan, Rajah Gary

Year : 2019| Volume: 5| Issue : 1 | Page no: 1-7

   This article has been cited by
1 Neuroprotection with the cannabigerol quinone derivative VCE-003.2 and its analogs CBGA-Q and CBGA-Q-Salt in Parkinsonæs disease using 6-hydroxydopamine-lesioned mice
Sonia Burgaz,Concepción García,María Gómez-Cañas,Carmen Navarrete,Adela García-Martín,Alain Rolland,Carmen del Río,María J. Casarejos,Eva Muñoz,Claudia Gonzalo-Consuegra,Eduardo Muñoz,Javier Fernández-Ruiz
Molecular and Cellular Neuroscience. 2021; 110: 103583
[Pubmed]  [Google Scholar] [DOI]
2 Allosteric modulation of the cannabinoid 2 receptor confers seizure resistance in mice
Lindsey Shapiro,Francesca Gado,Clementina Manera,Andrew Escayg
Neuropharmacology. 2021; : 108448
[Pubmed]  [Google Scholar] [DOI]
3 CB1R-dependent regulation of astrocyte physiology and astrocyte-neuron interactions
Ana Covelo,Abel Eraso-Pichot,Ignacio Fernández-Moncada,Román Serrat,Giovanni Marsicano
Neuropharmacology. 2021; : 108678
[Pubmed]  [Google Scholar] [DOI]
4 Untapped endocannabinoid pharmacological targets: pipe dream or pipeline?
Jenny L. Wilkerson,Joshua A. Bilbrey,Jasmine S. Felix,Alexandros Makriyannis,Lance R. McMahon
Pharmacology Biochemistry and Behavior. 2021; : 173192
[Pubmed]  [Google Scholar] [DOI]
5 “Photo-Rimonabant”: Synthesis and Biological Evaluation of Novel Photoswitchable Molecules Derived from Rimonabant Lead to a Highly Selective and Nanomolar “Cis-On” CB1R Antagonist
Diego A. Rodríguez-Soacha,Julia Fender,Yesid A. Ramírez,Juan Antonio Collado,Eduardo Muñoz,Rangan Maitra,Christoph Sotriffer,Kristina Lorenz,Michael Decker
ACS Chemical Neuroscience. 2021;
[Pubmed]  [Google Scholar] [DOI]
6 Endocannabinoid System of the Blood–Brain Barrier: Current Understandings and Therapeutic Potentials
Kofi Hagan, Panayiotis Varelas, HaiAn Zheng
Cannabis and Cannabinoid Research. 2021;
[Pubmed]  [Google Scholar] [DOI]
7 Targeting the CB 2 receptor and other endocannabinoid elements to delay disease progression in amyotrophic lateral sclerosis
Carmen Rodríguez-Cueto,Laura García-Toscano,Irene Santos-García,Marta Gómez-Almería,Claudia Gonzalo-Consuegra,Francisco Espejo-Porras,Javier Fernández-Ruiz,Eva Lago
British Journal of Pharmacology. 2021;
[Pubmed]  [Google Scholar] [DOI]
8 Correlation between matrix metalloproteinase-2 polymorphisms and first and recurrent atherosclerotic ischemic stroke events: a case–control study
Ying Li, Qing-rong Ouyang, Juan Li, Xiao-rong Chen, Lin-lin Li, Lei Xu, Ming Yu
Journal of International Medical Research. 2021; 49(6): 0300060521
[Pubmed]  [Google Scholar] [DOI]
9 Endocannabinoidome and its role in neurological disorders-A comprehensive update of existing literature
Rajib Dutta
Journal of Neuroscience and Neurological Disorders. 2021; 5(1): 034
[Pubmed]  [Google Scholar] [DOI]
10 Perspectives on Cannabis-Based Therapy of Multiple Sclerosis: A Mini-Review
Miriam Mecha,Francisco J. Carrillo-Salinas,Ana Feliú,Leyre Mestre,Carmen Guaza
Frontiers in Cellular Neuroscience. 2020; 14
[Pubmed]  [Google Scholar] [DOI]
11 Cannabinoid Receptors: An Update on Cell Signaling, Pathophysiological Roles and Therapeutic Opportunities in Neurological, Cardiovascular, and Inflammatory Diseases
Dhanush Haspula,Michelle A. Clark
International Journal of Molecular Sciences. 2020; 21(20): 7693
[Pubmed]  [Google Scholar] [DOI]
12 Study of the effectiveness of various cannabinoid receptor 1 (CB1) agonists using molecular docking and molecular dynamics modeling
Volodymyr Tkachenko,Vladimir Farafonov,Viktor Tokarev,Irina Tkachenko
French-Ukrainian Journal of Chemistry. 2020; 8(1): 76
[Pubmed]  [Google Scholar] [DOI]
13 A Systematic Review of Essential Oils and the Endocannabinoid System: A Connection Worthy of Further Exploration
Scott A. Johnson,Damian Rodriguez,Kathryn Allred
Evidence-Based Complementary and Alternative Medicine. 2020; 2020: 1
[Pubmed]  [Google Scholar] [DOI]
14 Safety Assessment of a Hemp Extract using Genotoxicity and Oral Repeat-Dose Toxicity Studies in Sprague-Dawley Rats
Margitta Dziwenka,Robert Coppock,McCorkle Alexander,Eddie Palumbo,Carlos Ramirez,Stephen Lermer
Toxicology Reports. 2020;
[Pubmed]  [Google Scholar] [DOI]
15 Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson’s and Alzheimer’s Diseases: a Review
R. Cooray,V. Gupta,C. Suphioglu
Molecular Neurobiology. 2020;
[Pubmed]  [Google Scholar] [DOI]
16 Characterization of CB2 Receptor Expression in Peripheral Blood Monocytes of Acute Ischemic Stroke Patients
Rosaria Greco,Chiara Demartini,Annamaria Zanaboni,Elena Tumelero,Candeloro Elisa,Alessandra Persico,Andrea Morotti,Diana Amantea,Cristina Tassorelli
Translational Stroke Research. 2020;
[Pubmed]  [Google Scholar] [DOI]
17 Administration of diphenyl diselenide (PhSe)2 following repetitive mild traumatic brain injury exacerbates anxiety-like symptomology in a rat model
Glenn R Yamakawa,Eric Eyolfson,Himanthri Weerawardhena,Richelle Mychasiuk
Behavioural Brain Research. 2020; : 112472
[Pubmed]  [Google Scholar] [DOI]
18 Ischemic Stroke In Neonatal And Adult Astrocytes
Miren Revuelta,Amaia Elicegui,Leire Moreno-Cugnon,Christoph Bührer,Ander Matheu,Thomas Schmitz
Mechanisms of Ageing and Development. 2019; : 111147
[Pubmed]  [Google Scholar] [DOI]


Read this article